EQS-News: Sartorius AG - Resolutions of the Annual General Meeting

Sartorius AG - Resolutions of the Annual General MeetingThe life science group Sartorius held its virtual Annual General Meeting today. The shareholders approved all proposals of the Supervisory Board and the Executive Board by a large majority, including the dividend proposal of 0.74 euros per preference share and 0.73 euros per ordinary share. The total amount disbursed will be 50.7 million euros, with the dividend to be paid out to shareholders on April 1, 2025. Further informationWebsite Annual General MeetingImage filesCVs and images of Executive Board and Supervisory BoardFinancial calendarApril 16, 2025                     Publication of the first quarter results January to March 2025 July 22, 2025                       Publication of the half-year results January to June 2025October 16, 2025             Publication of the nine-month results January to September 2025A profile of Sartorius Sartorius is a leading international partner of life sciences research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. The Bioprocess Solutions Division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and sustainably. The company, based in Göttingen, Germany, has a strong global reach with around 60 production and sales sites worldwide. Sartorius regularly expands its portfolio through the acquisition of complementary technologies. In 2024, the company generated sales revenue of around 3.4 billion euros. Around 13,500 employees are working for customers around the globe. Visit our Newsroom and follow Sartorius on LinkedIn.ContactLeona MalornyHead of External Communications+49 551 308 4067leona.malorny@sartorius.com